Wenfang He Chenfang Wu Yanjun Zhong Jinxiu Li Guyi Wang Bo Yu Ping Xu Yiwen Xiao Tiantian Tang
10.3389/fpubh.2022.899077
Front Public Health
2022 May 11;10:899077.
clindamycin intravenous immunoglobulin invasive group a streptococcal infections next-generation sequencing streptococcal toxic shock syndrome
CC BY
https://pubmed.ncbi.nlm.nih.gov/35646803/
Shock, Septic / diagnosis Shock, Septic / microbiology Shock, Septic / therapy Streptococcal Infections / drug therapy Streptococcal Infections / therapy
Shock, Septic / diagnosis Shock, Septic / microbiology Shock, Septic / therapy Streptococcal Infections / drug therapy Streptococcal Infections / therapy Case Reports Research Support, Non-U.S. Gov't Adult Anti-Bacterial Agents / therapeutic use Clindamycin / therapeutic use Debridement High-Throughput Nucleotide Sequencing Humans Immunoglobulins, Intravenous / therapeutic use Male Streptococcus pyogenes Anti-Bacterial Agents Immunoglobulins, Intravenous Clindamycin
PMC9130855
35646803
Case Report: Therapeutic Strategy With Delayed Debridement for Culture-Negative Invasive Group A Streptococcal Infections Diagnosed by Metagenomic Next-Generation Sequencing
2022